Lauschke VM

Engineering biomimetic tissue barrier models on chips: From design and fabrication to applications in disease modeling and drug screening.

Nasiri R, Madadelahi M, Nikmaneshi MR, ..., Khademhosseini A, Herland A

Biomaterials 327 (-) 123739 [2026-04-00; online 2025-09-23]

Primary Human Tissue Models for Metabolic Dysfunction-Associated Liver Disease - toward Streamlining Drug Discovery with Patient-Derived Assays.

Youhanna S, Taebnia N, Liang Y, ..., Michel M, Lauschke VM

Adv Biol (Weinh) 9 (12) e00337 [2025-12-00; online 2025-11-07]

Author Correction: Estrogen receptor activation remodels TEAD1 gene expression to alleviate hepatic steatosis.

Sommerauer C, Gallardo-Dodd CJ, Savva C, ..., Williams C, Kutter C

Mol Syst Biol 21 (9) 1282-1283 [2025-09-00; online 2025-06-12]

Claudia Kutter Erdinc Sezgin SciLifeLab Fellow

Chemogenomic Screening in a Patient-Derived 3D Fatty Liver Disease Model Reveals the CHRM1-TRPM8 Axis as a Novel Module for Targeted Intervention.

Youhanna S, Kemas AM, Wright SC, ..., Sundström M, Lauschke VM

Adv Sci (Weinh) 12 (3) e2407572 [2025-01-00; online 2024-11-28]

Compound Absorption in Polymer Devices Impairs the Translatability of Preclinical Safety Assessments.

Kemas AM, Zandi Shafagh R, Taebnia N, ..., Hofmann U, Lauschke VM

Adv Healthc Mater 13 (11) e2303561 [2024-04-00; online 2023-12-10]

Estrogen receptor activation remodels TEAD1 gene expression to alleviate hepatic steatosis.

Sommerauer C, Gallardo-Dodd CJ, Savva C, ..., Williams C, Kutter C

Mol Syst Biol 20 (4) 374-402 [2024-04-00; online 2024-03-08]

Claudia Kutter Erdinc Sezgin SciLifeLab Fellow

SAG1.3-derived Frizzled-targeting negative allosteric modulators

Schulte G, Grätz L, Turku A, ..., Löber S, Gmeiner P

- - (-) - [2024-02-20; online 2024-02-20]

Estrogen receptor activation remodels TEAD1 gene expression to alleviate nonalcoholic fatty liver disease

Sommerauer C, Gallardo-Dodd CJ, Savva C, ..., Williams C, Kutter C

- - (-) - [2023-09-08; online 2023-09-08]

Claudia Kutter Erdinc Sezgin SciLifeLab Fellow

JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality.

Stebbing J, Sánchez Nievas G, Falcone M, ..., Abizanda P, Lauschke VM

Sci Adv 7 (1) - [2021-01-00; online 2021-01-01]

Claudia Kutter SciLifeLab Fellow

Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk.

Zhou Y, Mägi R, Milani L, Lauschke VM

J. Lipid Res. 59 (10) 1987-2000 [2018-10-00; online 2018-08-03]